Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2006 2
2007 3
2008 3
2009 4
2010 2
2011 6
2012 6
2013 11
2014 10
2015 5
2016 8
2017 8
2018 7
2019 13
2020 18
2021 30
2022 26
2023 27
2024 32
2025 49
2026 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

266 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Tumor microenvironment and metabolic reprogramming in cancer.
Cui X, Liu X, Feng R, Wang X, Wei Y, Zhu H, Raza A, Zhu X, Chen H, Chong W. Cui X, et al. Among authors: chong w. Front Immunol. 2024 Oct 8;15:1497966. doi: 10.3389/fimmu.2024.1497966. eCollection 2024. Front Immunol. 2024. PMID: 39439797 Free PMC article. No abstract available.
Total neoadjuvant treatment with short-course radiotherapy followed by sintilimab plus capecitabine-oxaliplatin versus short-course radiotherapy followed by capecitabine-oxaliplatin in patients with locally advanced rectal cancer (SPRING-01): a single-centre, open-label, phase 2, randomised controlled trial.
Tian F, Dai H, Sha D, Yu Y, Jing H, Sun C, Shang L, Liu Y, Feng R, Li J, Liu H, Chen Y, Shi Y, Wang J, Zhuo H, Zhang X, Lian G, Chong W, Chen H, Yang Z, Li L, Jing C. Tian F, et al. Among authors: chong w. Lancet Oncol. 2025 Aug;26(8):1043-1054. doi: 10.1016/S1470-2045(25)00286-4. Epub 2025 Jul 8. Lancet Oncol. 2025. PMID: 40645192 Clinical Trial.
266 results